Last reviewed · How we verify
NCT04490720
The Efficacy Evaluation of Buckwheat Husk Extract on Cardiovascular Disease Risk Factors
NA trial testing Placebo in Cardiovascular Diseases in 60 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | TCI Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 24 November 2021 |
| Primary completion | 31 December 2025 |
| Estimated completion | 28 February 2026 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Placebo
- Buckwheat husk extract
Conditions studied
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Sponsor
TCI Co., Ltd. — full company profile →
Who can join
Adults 20 to 65, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assess the efficacy evaluation of buckwheat husk extract on cardiovascular disease risk factors
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04490720
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular Diseases
Currently open trials in the same condition.
- NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
- NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other TCI Co., Ltd. trials
Trials by the same sponsor.
- NCT07379216 — Efficacy Evaluation Study of Vitamin C and Glutathione Liquid Sachet · NA · recruiting
- NCT07302828 — Effect of Double Nutri® Liposomal Encapsulation Technology on Human Absorption of Vitamin C and Glutathione Liquid Sache · NA · completed
- NCT07172607 — The Effect of Avnace eZZe on Sleep Improvement · NA · recruiting
- NCT07097987 — Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion · NA · not yet recruiting
- NCT07097974 — Evaluation of the Efficacy of the Composite WM Formula in Body Weight Change · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04490720 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TCI Co., Ltd.
- Last refreshed: 9 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04490720.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing